Current Evidence and Future Perspectives in the Management of Nonmetastatic Upper Tract Urothelial Carcinoma


Por: Lenfant, L, Breda, A, Xylinas, E, Babjuk, M, Moschini, M, Roupret, M, Board, TESOOUBESOUE

Publicada: 1 ago 2022 Ahead of Print: 1 jul 2022
Resumen:
This case-based discussion describes the management of a 66-yr-old man who presented to the emergency department with gross hematuria. His urine cytology was benign, and computed tomography (CT) with nephrographic phase revealed a 2.5 cm filling defect within the left renal pelvis and luminal narrowing in the right proximal ureter with hydronephrosis. CT showed no lymphadenopathy and no sign of metastatic disease. Cystoscopy was normal. In a progressive case-based discussion fashion, we will discuss the diagnostic and treatment options with two different perspectives: (1) guidelines-based current standard of care and (2) an outlook on future perspectives using the latest scientific advances that may soon become the standard of care. Patient summary: This presentation of a real-life clinical scenario will be useful in describing the current standard of care and future perspectives regarding the diagnosis and treatment of upper urinary tract tumors. (C) 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Filiaciones:
Lenfant, L:
 Sorbonne Univ, Hop Pitie Salpetriere, Urol,GRC ndeg5, Predict Onco Urol, Paris, France

Breda, A:
 Autonomous Univ Barcelona, Dept Urol, Fundacio Puigvert, Barcelona, Spain

Xylinas, E:
 Paris Univ, Bichat Claude Bernard Hosp, Assistance Publ Hop Paris, Dept Urol, Paris, France

Babjuk, M:
 Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria

 Charles Univ Prague, Hosp Motol, Fac Med 2, Dept Urol, Prague, Czech Republic

 Charles Univ Prague, Hosp Motol, Prague, Czech Republic

Moschini, M:
 Luzerner Kantonssp, Klin fair Urol, Luzern, Switzerland

Roupret, M:
 Sorbonne Univ, Hop Pitie Salpetriere, Urol,GRC ndeg5, Predict Onco Urol, Paris, France

 Sorbonne Univ, Hop Pitie Salpetriere, Predict Onco Urol, APHP,GRC ndeg5, 83 Blvd Hop, F-75013 Paris, France
ISSN: 25889311
Editorial
ELSEVIER, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 5 Número: 4
Páginas: 464-471
WOS Id: 000843280400013
ID de PubMed: 34561205

MÉTRICAS